Literature DB >> 6330306

Chronic polyneuropathy of undetermined cause.

J G McLeod, R R Tuck, J D Pollard, J Cameron, J C Walsh.   

Abstract

The case histories of 519 patients with peripheral neuropathy on whom sural nerve biopsy had been performed were reviewed. In 67 patients (50 males, 17 females) (13%) who had symptoms of a symmetrical polyneuropathy for more than one year, the cause remained undiagnosed in spite of intensive investigation. Patients with inflammatory neuropathy were not included, but represented 17% of the whole series. The mean age of onset of symptoms was 50.6 years, and the median time from onset of symptoms to initial investigation was 2 years. Males were affected more commonly than females in a ratio of 3:1. The clinical features in 43 patients were those of a mixed motor and sensory neuropathy, in 17 patients a predominantly sensory neuropathy and in 7 patients a predominantly motor neuropathy. The mean CSF protein was 0.73 g/l and in only six patients was it greater than 1 g/l. Nerve conduction studies most commonly demonstrated mild slowing of motor conduction and impairment of sensory conduction. The usual pathological changes on sural nerve biopsy were those of chronic axonal degeneration. Forty seven patients (70%) were re-examined at intervals of time which ranged from 4 months to 12 years after their initial presentation and nerve biopsy (median, 3 years). As a group, they were only mildly disabled, the condition had a very slowly progressive course and there had been little change in their disability. A possible aetiological factor was found in 17 of the 47 patients (36%) and included malignancy, alcoholism, and benign paraproteinaemia. It is concluded that with intensive investigation the cause of chronic polyneuropathy of duration greater than one year remains undetermined in only about 13% of patients and that continued follow-up is worthwhile since a diagnosis may be established on re-examination.

Entities:  

Mesh:

Year:  1984        PMID: 6330306      PMCID: PMC1027832          DOI: 10.1136/jnnp.47.5.530

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Chronic inflammatory polyradiculoneuropathy.

Authors:  P J Dyck; A C Lais; M Ohta; J A Bastron; H Okazaki; R V Groover
Journal:  Mayo Clin Proc       Date:  1975-11       Impact factor: 7.616

2.  Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone.

Authors:  J H AUSTIN
Journal:  Brain       Date:  1958-06       Impact factor: 13.501

3.  Polyneuropathies of undetermined cause.

Authors:  J Prineas
Journal:  Acta Neurol Scand Suppl       Date:  1970

4.  Recurrent and chronic relapsing Guillain-Barré polyneuritis.

Authors:  P K Thomas; R G Lascelles; J F Hallpike; R L Hewer
Journal:  Brain       Date:  1969       Impact factor: 13.501

5.  Total lipodystrophy--a report of a case with peripheral neuropathy and glomerulonephritis.

Authors:  R R Tuck; J G McLeod; A Basten; D Ellis; P D Kirwan
Journal:  Aust N Z J Med       Date:  1983-02

6.  Chronic relapsing polyneuritis.

Authors:  J W Prineas; J G McLeod
Journal:  J Neurol Sci       Date:  1976-04       Impact factor: 3.181

7.  Hypertrophic Charcot-Marie-Tooth disease. Light and electron microscope studies of the sural nerve.

Authors:  P A Low; J G McLeod; J W Prineas
Journal:  J Neurol Sci       Date:  1978-01       Impact factor: 3.181

8.  Chronic cryptogenic polyneuropathy. The search for a cause.

Authors:  J Fagius
Journal:  Acta Neurol Scand       Date:  1983-03       Impact factor: 3.209

9.  Peripheral neuropathy in spinocerebellar degenerations.

Authors:  J G McLeod; W A Evans
Journal:  Muscle Nerve       Date:  1981 Jan-Feb       Impact factor: 3.217

  9 in total
  26 in total

Review 1.  Immunological mechanisms in paraneoplastic peripheral neuropathy.

Authors:  J C Antoine
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

3.  Tests and expenditures in the initial evaluation of peripheral neuropathy.

Authors:  Brian Callaghan; Ryan McCammon; Kevin Kerber; Xiao Xu; Kenneth M Langa; Eva Feldman
Journal:  Arch Intern Med       Date:  2012-01-23

4.  Distal peripheral polyneuropathy in a great dane.

Authors:  P M Henricks; J Steiss; J D Petterson
Journal:  Can Vet J       Date:  1987-04       Impact factor: 1.008

5.  The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings.

Authors:  K B Yeung; P K Thomas; R H King; H Waddy; R G Will; R A Hughes; N A Gregson; S Leibowitz
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

6.  Chronic inflammatory demyelinating polyneuropathy in two siblings.

Authors:  A A Gabreëls-Festen; A T Hageman; F J Gabreëls; E M Joosten; W O Renier; C M Weemaes; H J ter Laak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

Review 7.  Should coeliac disease be considered in the work up of patients with chronic peripheral neuropathy?

Authors:  N R Rosenberg; M Vermeulen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

8.  Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP).

Authors:  Peter G Erdmann; Laurien L Teunissen; Frank R van Genderen; Nicolette C Notermans; Eline Lindeman; Paul J M Helders; Nico L U van Meeteren
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

9.  Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients.

Authors:  N C Notermans; J H Wokke; H Franssen; Y van der Graaf; M Vermeulen; L H van den Berg; P R Bär; F G Jennekens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

10.  Feasibility and cost efficiency of a diagnostic guideline for chronic polyneuropathy: a prospective implementation study.

Authors:  A F J E Vrancken; S Kalmijn; E Buskens; H Franssen; M Vermeulen; J H J Wokke; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.